Analyst Price Targets — KRSA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| September 14, 2026 8:51 am | — | Stifel Nicolaus | $43.00 | $31.91 | TheFly | Korsana Biosciences initiated with a Buy at Stifel |
| September 10, 2026 10:10 pm | — | UBS | $55.00 | $24.56 | TheFly | Korsana Biosciences initiated with a Buy at UBS |
Latest News for KRSA
Korsana Biosciences Completes Closing of Merger with Cyclerion Therapeutics and Previously Announced Private Placement of $380 Million
Advancing lead program KRSA-028 toward the clinic, with Phase 1 healthy volunteer data expected mid-2027 and interim proof-of-concept data in Alzheimer's patients anticipated by year-end 2027 or first quarter of 2028
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for KRSA.
U.S. House Trading
No House trades found for KRSA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.